4basebio PLC (FRA:88Q)
Germany · Delayed Price · Currency is EUR 6.85
0.00 (0.00%)
At close: Jan 9, 2026
4basebio Market Cap
4basebio has a market cap or net worth of €105.24 million as of January 9, 2026. Its market cap has decreased by -42.55% in one year.
Market Cap
105.24M
Enterprise Value
92.94M
Revenue
2.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.85
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 47.83M to 105.24M, an increase of 120.03%. That is a compound annual growth rate of 17.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 105.24M | -3.55% |
| Dec 31, 2025 | 109.11M | -41.76% |
| Dec 31, 2024 | 187.36M | 94.08% |
| Dec 29, 2023 | 96.54M | -2.09% |
| Dec 30, 2022 | 98.60M | 9.32% |
| Dec 31, 2021 | 90.19M | 88.56% |
| Feb 17, 2021 | 47.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |